EVAX

EVAX

USD

Evaxion Biotech A/S American Depositary Share

$5.600+0.030 (0.539%)

Preço em tempo real

Healthcare
Biotecnologia
Dinamarca

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$5.570

Máximo

$6.010

Mínimo

$5.570

Volume

0.09M

Fundamentos da empresa

Capitalização de mercado

44.4M

Setor

Biotecnologia

País

Denmark

Estatísticas de negociação

Volume médio

1.59M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $1.2Atual $5.600Máximo $13.8

Notícias relacionadas

GlobeNewswire

Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate

Evaxion introduces EVX-04, a novel vaccine candidate targeting multiple non-conventional ERV tumor antigens, developed with our AI-Immunology™ platformEVX-04 is a therapeutic cancer vaccine candidate designed for

Ver mais
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
GlobeNewswire

Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline. COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a

Ver mais
Correction: Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025
GlobeNewswire

Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025

COPENHAGEN, Denmark, October 31, 2025 - Evaxion A/S (NASDAQ:EVAX) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report

Ver mais
Evaxion to announce business update and third quarter 2025 financial results on November 6, 2025